文献速递牙周病

改良微创手术技术治疗人类骨内缺损联合或不联合再生材料的10年随访随机临床试验:牙齿存留、牙周炎复发与成本

Modified minimally invasive surgical technique in human intrabony defects with or without regenerative materials-10-year follow-up of a randomized clinical trial: Tooth retention, periodontitis recurrence, and costs.
PubMed 文献 · J Clin Periodontol · 2022-04-25

45例骨内缺损患者随机接受单纯改良微创手术技术(M-MIST)、联合釉基质衍生物(EMD)或联合EMD与骨矿物质来源异种骨(BMDX)治疗,随访10年。三组临床附着水平变化无显著差异,无并发症生存率无显著差异,单纯M-MIST总成本较低。结论需更大规模独立研究确认。

要点

  • 三组10年临床附着水平变化无显著差异,组内及组间比较P值均大于0.05。
  • 无并发症生存率三组无显著差异(P=0.47),全人群为7.46年(95%CI 7.05-7.87)。
  • 考虑基线治疗成本时,单纯M-MIST的10年总成本较低。

核心结论

  • 伴有深牙周袋的骨内缺损患牙可通过单纯M-MIST或在仔细牙周支持治疗项目下联合再生材料实现长期成功维护。
  • 单纯M-MIST在短期和长期获益方面与再生治疗相似,且成本更低。
  • 这些发现需要在更大规模的独立研究中确认。

研究设计与样本

  • 随机临床试验,45例患者的45个骨内缺损随机分为三组:单纯M-MIST组(N=15)、M-MIST+EMD组(N=15)、M-MIST+EMD+BMDX组(N=15),随访10年,期间提供牙周支持治疗(SPC)和必要的再治疗。

主要发现

  • 1年至10年临床附着水平变化:M-MIST组为-0.1±0.7 mm,M-MIST+EMD组为-0.1±0.8 mm,M-MIST+EMD+BMDX组为-0.3±0.6 mm,组内及组间差异P值均大于0.05。
  • 复发事件:M-MIST组4次,M-MIST+EMD组4次,M-MIST+EMD+BMDX组5次。
  • 无并发症生存率三组间无显著差异(P=0.47),全人群无并发症生存时间为7.46年(95%置信区间:7.05-7.87)。
  • M-MIST+EMD+BMDX组丢失1颗治疗牙。
  • 10年复发总成本组间无显著差异;考虑基线治疗成本时,单纯M-MIST组总成本较低。

关键数值与推荐

  • 1年至10年临床附着水平变化:M-MIST组-0.1±0.7 mm,M-MIST+EMD组-0.1±0.8 mm,M-MIST+EMD+BMDX组-0.3±0.6 mm(组内及组间P>0.05)。
  • 无并发症生存率组间比较P=0.47;全人群无并发症生存时间7.46年(95%CI 7.05-7.87)。
  • 复发事件数:M-MIST组4次,M-MIST+EMD组4次,M-MIST+EMD+BMDX组5次。

临床怎么用

  • 作者认为,在仔细的牙周支持治疗项目下,单纯M-MIST或联合再生材料均可长期成功维护伴有深牙周袋的骨内缺损患牙。
  • 作者指出,单纯M-MIST提供了与再生治疗相似的短期和长期获益,且成本更低。
  • 作者表示这些发现需要在更大规模的独立研究中确认。

局限性

  • 3名受试者失访。
  • 这些发现需要在更大规模的独立研究中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The modified minimally invasive surgical technique (M-MIST) optimizes wound stability in the treatment of intrabony defects. Short-term observations show similar results as with flap alone or adjunctive regenerative materials. This study aims to compare the stability of the long-term outcomes, complication-free survival, and costs of the three treatment options. MATERIALS AND METHODS: Forty-five intrabony defects in 45 patients were randomized to M-MIST alone (N = 15), combined with enamel matrix derivative (M-MIST + EMD, N = 15), or EMD plus bone-mineral-derived xenograph (M-MIST + EMD + BMDX, N = 15). Supportive periodontal care (SPC) and necessary re-treatment were provided for 10 years. RESULTS: Three subjects were lost to follow-up. Clinical attachment level differences between 1 and 10 years were -0.1 ± 0.7 mm for M-MIST, -0.1 ± 0.8 mm for M-MIST + EMD, and -0.3 ± 0.6 mm for M-MIST + EMD + BMDX (p > .05 for within- and between-group differences). Four episodes of recurrence occurred in the M-MIST group, four in the M-MIST + EMD group, and five in the M-MIST + EMD + BMDX group. No significant differences in complication-free survival were observed between the three groups (p = .47). Complication-free survival was 7.46 years (95% confidence interval: 7.05-7.87) for the whole population. The M-MIST + EMD + BMDX group lost one treated tooth. Data indicated no significant inter-group difference of the total cost of recurrence over 10 years. When the baseline cost of treatment was considered, the total cost was lower for M-MIST alone. CONCLUSIONS: Teeth with deep pockets associated with intrabony defects can be successfully maintained over the long term with either M-MIST alone or by adding a regenerative material in the context of a careful SPC programme. M-MIST alone provided similar short- and long-term benefits as regeneration, at a lower cost. These findings need to be confirmed in larger, independent studies.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Cortellini P, Cortellini S, Bonaccini D, et al. Modified minimally invasive surgical technique in human intrabony defects with or without regenerative materials-10-year follow-up of a randomized clinical trial: Tooth retention, periodontitis recurrence, and costs. J Clin Periodontol. 2022. PMID: 35415940. doi:10.1111/jcpe.13627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。